Skip to content
Entourage
Case studyPharma

Operational Due Diligence for an M&A Integration

Life-sciences manufacturing company in the course of an acquisition

In the course of a merger, inconsistent compliance and limited standardization shaped the operations of the newly combined organization.

The challenge

The situation

In the course of a merger, the company faced inconsistent compliance and limited standardization in its operations. The absence of standardized processes and quality management systems posed a considerable risk to the integration and optimization of the newly combined organization.

Our approach

What we delivered

01

Review of regulatory affairs compliance, because inconsistent compliance is the first integration risk in any merger.

02

Evaluation of the supply chain at the points where two organisations with different standards come together.

03

Assessment of the digital systems, so that it is established before the merger which quality management systems are compatible at all.

The outcome

Results & impact

Three assessment areas

Due diligence across regulatory affairs, supply chain and digital systems.

Integration risks identified

Transparency created over the organization's compliance and integration gaps.

In summary

The operational due diligence makes the transaction's compliance and integration risks transparent and creates a sound basis for combining the organization.

Sources
  • Entourage project experience (anonymised)

Your project

A comparable project?

Briefly outline your situation. We'll respond with an initial assessment, usually within one business day.

Prefer direct? +49 89 4161170-0
info@theentourage.de

  • Reply usually within one working day
  • 4 offices: DE · CH · IT · US
  • 100% life sciences